jueves, 28 de febrero de 2019

2019 Oncology Center of Excellence Childhood Cancer Advocacy Forum - Drug Information Update

The Division of Drug Information (DDI) - serving the public by providing information on human drug products and drug product regulation by FDA


2019 Oncology Center of Excellence Childhood Cancer Advocacy Forum

Friday, March 15, 2019
9:00 a.m. – 1:00 p.m. EST


Register here for in-person or online attendance. 

Location: 
FDA White Oak Campus
10903 New Hampshire Avenue
Bldg. 31 Conference Center, the Great Room (Rm. 1503, Section A)
Silver Spring, MD 20993-0002

Topics for Discussion:
  • FDA’s External Engagement and Patient Advocacy: A Dialogue to Better Inform FDA of Patient Needs and Priorities
  • Avoiding Pitfalls in Drug Development
  • Approved Cancer Drugs in Children
  • BPCA/WR Study Results
  • Expanded Access to Investigational Drugs
  • FDARA Implementation
  • Pediatric PROs: Are they feasible?

No hay comentarios:

Publicar un comentario